⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of SpectraCure AB and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
SpectraCure AB
↗Lund, Sweden
SpectraCure is a medical technology company based in Lund, Sweden, focused on developing advanced interstitial photodynamic therapy (PDT) systems for the treatment of internal solid tumors. Their proprietary platform, which includes the Q-PRO® laser device and the IDOSE® dose-planning software, allows for precise, image-guided, and minimally invasive cancer treatment.
The company initially focuses on recurrent and primary prostate cancer, with the long-term goal of adapting its technology for other solid tumors such as breast, pancreatic, and head and neck cancers. SpectraCure operates as a publicly traded entity and maintains a strategy of collaborating with leading clinical centers in North America and Europe to build clinical evidence and secure market approvals.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2003
Ownership:public
Status:operating
FUNDING
Stage:Public
Investors:Karolinska Development AB, Industrifonden, Östersjöstiftelsen
STOCK
Exchange:Nasdaq First North Growth Market
Ticker:SPEC
Market Cap:$0.003B
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 2 (Clinical trials for recurrent prostate cancer)
Modalities:Photodynamic Therapy (PDT), Medical Device
Active Trials:2
Trial Phases:Phase 1: 1 | Phase 2: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:MedCom GmbH (Imaging technology integration), Princess Margaret Cancer Centre (Clinical partner), University of Pennsylvania Hospital (Clinical partner), University College London Hospital (Clinical partner)
COMPETITION
Position:Niche Player
Competitors:PhotoPharmics, Illumi Medical, ImPact Biotech, Photolitec
LEADERSHIP
Key Executives:
Johan Folkunger - CEO
Johannes Swartling - CTO
Scientific Founders:Sune Svanberg, Katarina Svanberg, Stefan Andersson-Engels
LINKS
Website:spectracure.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with SpectraCure AB. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.